Osteopontin (OPN) is among the several gene products aberrantly expressed in CRC [6], and increased OPN plasma levels are potentially related to the occurrence of metastasis and poor prognosis in CRC patients [6,7]. Here, SPP1 is linked to colorectal carcinoma.